(Q34037683)

24 June 2018

title

Efficacy of remission-induction regimens for ANCA-associated vasculitis (English)

1 reference

24 June 2018

7

Cees G M Kallenberg

1 reference

24 June 2018

E. William St. Clair

8

E William St Clair

1 reference

24 June 2018

Carol A Langford

5

Carol A Langford

1 reference

24 June 2018

Paul A Monach

24

Paul A Monach

1 reference

24 June 2018

Coen A Stegeman

26

Coen Stegeman

1 reference

24 June 2018

Gary S Hoffman

6

Gary S Hoffman

1 reference

24 June 2018

Peter A Merkel

2

Peter A Merkel

1 reference

24 June 2018

Ulrich Specks

1

Ulrich Specks

1 reference

24 June 2018

John H Stone

31

John H Stone

1 reference

24 June 2018

Robert Spiera

4

Robert Spiera

1 reference

24 June 2018

Nadia Tchao

12

Nadia K Tchao

1 reference

24 June 2018

Linna Ding

10

Linna Ding

1 reference

24 June 2018

Steven Yariv

27

Steven R Ytterberg

1 reference

24 June 2018

Philip Seo

3

Philip Seo

1 reference

24 June 2018

author name string

Barri J Fessler

9

1 reference

24 June 2018

Lisa Viviano

11

1 reference

24 June 2018

Deborah J Phippard

13

1 reference

24 June 2018

Adam L Asare

14

1 reference

24 June 2018

Noha Lim

15

1 reference

24 June 2018

David Ikle

16

1 reference

24 June 2018

Brett Jepson

17

1 reference

24 June 2018

Paul Brunetta

18

1 reference

24 June 2018

Nancy B Allen

19

1 reference

24 June 2018

Fernando C Fervenza

20

1 reference

24 June 2018

Duvuru Geetha

21

1 reference

24 June 2018

Karina Keogh

22

1 reference

24 June 2018

Eugene Y Kissin

23

1 reference

24 June 2018

Tobias Peikert

25

1 reference

24 June 2018

Mark Mueller

28

1 reference

24 June 2018

Lourdes P Sejismundo

29

1 reference

24 June 2018

Kathleen Mieras

30

1 reference

24 June 2018

RAVE-ITN Research Group

32

1 reference

24 June 2018

language of work or name

English

0 references

publication date

1 August 2013

1 reference

24 June 2018

The New England Journal of Medicine

published in

1 reference

24 June 2018

volume

369

1 reference

24 June 2018

issue

5

1 reference

24 June 2018

page(s)

417-427

1 reference

24 June 2018

Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Etanercept plus standard therapy for Wegener's granulomatosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Prediction of creatinine clearance from serum creatinine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Azathioprine or methotrexate maintenance for ANCA-associated vasculitis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

Wegener Granulomatosis: An Analysis of 158 Patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5953195

The effect of cyclophosphamide on B and T lymphocytes in patients with connective tissue diseases

29 October 2018

1 reference

12 December 2020

Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

12 December 2020

A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

12 December 2020

Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation

1 reference

12 December 2020

Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies

1 reference

12 December 2020

A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)

1 reference

12 December 2020

Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides

1 reference

12 December 2020

Suppression of human B lymphocyte function by cyclophosphamide

1 reference

12 December 2020

Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis

1 reference

12 December 2020

Differential B- and T-cell activation in Wegener's granulomatosis

1 reference

12 December 2020

ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis

1 reference

12 December 2020

Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades

1 reference

12 December 2020

A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA1213277

1 reference

24 June 2018

PMCID

5953195

1 reference

24 June 2018

PubMed ID

23902481

1 reference

24 June 2018